Show simple item record

AuthorAbedin Zadeh M.
AuthorKhoder M.
AuthorAl-Kinani A.A.
AuthorYounes H.M.
AuthorAlany R.G.
Available date2020-04-27T08:34:19Z
Publication Date2019
Publication NameDrug Discovery Today
ResourceScopus
ISSN13596446
URIhttp://dx.doi.org/10.1016/j.drudis.2019.04.009
URIhttp://hdl.handle.net/10576/14551
AbstractDegenerative retinal diseases, such as age-related macular degeneration (AMD), can lead to permanent sight loss. Although intravitreal anti-vascular endothelial growth factor (VEGF) and steroid injections are effective for the management of early stages of wet and/or neovascular AMD (nAMD), no proven treatments currently exist for dry AMD or for the advanced geographic atrophy of the retina that follows. Tissue engineering (TE) has recently emerged as a promising alternative to repair retinal damaged and restore its functions. Here, we review recent advances in TE, with a particular emphasis on retinal regeneration. We provide an overview of retinal diseases, followed by a comprehensive review of TE techniques, cells, and polymers used in the fabrication of scaffolds for retinal cell regenerations, in particular the retinal pigment epithelium (RPE). - 2019
Languageen
PublisherElsevier Ltd
SubjectRetinal Pigment Epithelium
Stem Cells
Subretinal space
TitleRetinal cell regeneration using tissue engineered polymeric scaffolds
TypeArticle Review
Pagination1669-1678
Issue Number8
Volume Number24
dc.accessType Abstract Only


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record